Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats

Brain Research

Volumn 1421, Issue , 2011, Pages 110-120

  Yamada, Koji ^a   Horita, Takako ^a   Takayama, Makoto ^a   Takahashi, Shusuke ^a   Takaba, Katsumi ^a   Nagata, Yoshinori ^a   Suzuki, Nobuyuki ^a   Kanda, Tomoyuki ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Cholinergic neurotransmission; Chronic cerebral hypo perfusion; Enalapril; Imidapril; Novel object recognition; Vascular dementia

Indexed keywords

ACETYLCHOLINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; IMIDAPRIL; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN PERFUSION; CHOLINERGIC TRANSMISSION; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ENZYME ACTIVITY; LIPOPHILICITY; LOCOMOTION; MALE; MULTIINFARCT DEMENTIA; NONHUMAN; PERIRHINAL CORTEX; PRIORITY JOURNAL; RAT; RECOGNITION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TISSUE DISTRIBUTION;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BRAIN; COGNITION; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; MICRODIALYSIS; PERINDOPRIL; RATS; RATS, INBRED SHR; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 80055005001     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.09.016     Document Type: Article

References (53)

1. H. Abe, Y. Ishida, and T. Iwasaki Perirhinal N-methyl-d-aspartate and muscarinic systems participate in object recognition in rats Neurosci. Lett. 356 3 2004 191 194 (Pubitemid 38186684)
2. 3H]acetylcholine from rat entorhinal cortex in vitro Brain Res. 491 1989 136 143 (Pubitemid 19159084)
3. J.M. Barnes, N.M. Barnes, B. Costall, Z.P. Horovitz, J.W. Ironside, R.J. Naylor, and T.J. Williams Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition Brain Res. 507 1990 341 343 (Pubitemid 20054121)
4. J.S. Bonini, L.R. Bevilaqua, C.G. Zinn, D.S. Kerr, J.H. Medina, I. Izquierdo, and M. Cammarota Angiotensin II disrupts inhibitory avoidance memory retrieval Horm. Behav. 50 2006 308 313 (Pubitemid 44041349)
5. M.A. Cascieri, H.G. Bull, R.A. Mumford, A.A. Patchett, N.A. Thornberry, and T. Liang Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422 Mol. Pharmacol. 25 1984 287 293 (Pubitemid 14173337)
6. S.H. Croog, S. Levine, M.A. Testa, B. Brown, C.J. Bulpitt, C.D. Jenkins, G.L. Klerman, and G.H. Williams The effects of antihypertensive therapy on the quality of life N. Engl. J. Med. 314 1986 1657 1664 (Pubitemid 16097842)
7. N.M. Davies, P.G. Kehoe, Y. Ben-Shlomo, and R.M. Martin Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias J. Alzheimers Dis. 2011 10.3233/JAD-2011-110347 Electronic publication ahead of print. (Online Date; June 27, 2011, http://iospress. metapress.com/content/r83w488318829403/)
8. M.C. de Wilde, E. Farkas, M. Gerrits, A.J. Kiliaan, and P.G. Luiten The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion Brain Res. 947 2 2002 166 173
9. Y.F. Dong, K. Kataoka, Y. Tokutomi, H. Nako, T. Nakamura, K. Toyama, D. Sueta, N. Koibuchi, E. Yamamoto, H. Ogawa, and S. Kim-Mitsuyama Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease FASEB J. 25 9 2011 2911 2920
10. E.A. Eckman, S.K. Adams, F.J. Troendle, B.A. Stodola, M.A. Kahn, A.H. Fauq, H.D. Xiao, K.E. Bernstein, and C.B. Eckman Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme J. Biol. Chem. 281 2006 30471 30478 (Pubitemid 44582103)
11. J. Ellul, N. Archer, C.M. Foy, M. Poppe, H. Boothby, H. Nicholas, R.G. Brown, and S. Lovestone The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration J. Neurol. Neurosurg. Psychiatry 78 2007 233 239 (Pubitemid 46579658)
12. A. Ennaceur, A. Cavoy, J.C. Costa, and J. Delacour A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam Behav. Brain Res. 33 1989 197 207 (Pubitemid 19141068)
13. E. Farkas, P.G. Luiten, and F. Bari Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases Brain Res. Rev. 54 1 2007 162 180 (Pubitemid 46498166)
14. R. Ferrari Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril Expert. Rev. Cardiovasc. Ther. 3 1 2005 15 29
15. L. Ferrington, J.S. Miners, L.E. Palmer, S.M. Bond, J.E. Povey, P.A. Kelly, S. Love, K.J. Horsburgh, and P.G. Kehoe Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease Am. J. Transl. Res. 3 2011 197 208
16. G.R. Hanson, and W. Lovenberg Elevation of substance P-like immunoreactivity in rat central nervous system by protease inhibitors J. Neurochem. 35 1980 1370 1374 (Pubitemid 11172133)
17. R.U. Hasenöhrl, M.A. Souza-Silva, S. Nikolaus, C. Tomaz, M.L. Brandao, R.K. Schwarting, and J.P. Huston Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery Neuropeptides 34 5 2000 272 280
18. M. He, T. Ohrui, M. Maruyama, N. Tomita, K. Nakayama, M. Higuchi, K. Furukawa, and H. Arai ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease Neurology 67 7 2006 1309 1310 (Pubitemid 44563857)
19. M.L. Hemming, D.J. Selkoe, and W. Farris Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease Neurobiol. Dis. 26 2007 273 281 (Pubitemid 46436503)
20. D.R. Hou, Y. Wang, L. Zhou, K. Chen, Y. Tian, Z. Song, J. Bao, and Q.D. Yang Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease Chin. Med. J. (Engl.) 121 22 2008 2320 2323
21. T.A. Jenkins, and S.Y. Chai Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats Neurobiol. Learn. Mem. 87 2007 218 224 (Pubitemid 46038950)
22. H.J. Ji, J.F. Hu, Y.H. Wang, X.Y. Chen, R. Zhou, and N.H. Chen Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus Eur. J. Pharmacol. 636 2010 96 101
23. E.H. Kerns, L. Di, S. Petusky, T. Kleintop, D. Huryn, O. McConnell, and G. Carter Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectrometry J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 791 1-2 2003 381 388 (Pubitemid 36638771)
24. D.S. Kerr, L.R. Bevilaqua, J.S. Bonini, J.I. Rossato, C.A. Köhler, J.H. Medina, I. Izquierdo, and M. Cammarota Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism Psychopharmacology (Berl.) 179 2005 529 535 (Pubitemid 40674753)
25. L. Kilander, H. Nyman, M. Boberg, L. Hansson, and H. Lithell Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men Hypertension 31 3 1998 780 786 (Pubitemid 28108576)
26. M. Kouznetsova, and A. Nistri Facilitation of cholinergic transmission by substance P methyl ester in the mouse hippocampal slice preparation Eur. J. Neurosci. 12 2 2000 585 594 (Pubitemid 30142760)
27. M. Kubo, J. Kato, T. Ochiai, and R. Ishida Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities Jpn. J. Pharmacol. 53 2 1990 201 210 (Pubitemid 20184417)
28. D. Kumaran, M. Udayabanu, M. Kumar, R. Aneja, and A. Katyal Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats Neuroscience 155 2008 626 639
29. N.C. Li, A. Lee, R.A. Whitmer, M. Kivipelto, E. Lawler, L.E. Kazis, and B. Wolozin Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis BMJ 340 2010 b5465
30. oct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds J. Med. Chem. 44 15 2001 2490 2497 (Pubitemid 32852170)
31. S.M. Manschot, G.J. Biessels, N.E. Cameron, M.A. Cotter, A. Kamal, L.J. Kappelle, and W.H. Gispen Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats Brain Res. 966 2003 274 482
32. S. Miners, E. Ashby, S. Baig, R. Harrison, H. Tayler, E. Speedy, J.A. Prince, S. Love, and P.G. Kehoe Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes Am. J. Transl. Res. 1 2009 163 177
33. S. Moriyama, Y. Ishigai, T. Mori, A. Fukuzawa, and T. Shibano Evaluation of high through-to-peak ratio of perindopril in SHR Clin. Exp. Hypertens. 21 7 1999 1223 1238 (Pubitemid 29462791)
34. T. Ohrui, N. Tomita, T. Sato-Nakagawa, T. Matsui, M. Maruyama, K. Niwa, H. Arai, and H. Sasaki Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression Neurology 63 2004 1324 1325 (Pubitemid 39350046)
35. M.S. Oitzl, R.U. Hasenöhrl, and J.P. Huston Reinforcing effects of peripherally administered substance P and its C-terminal sequence pGlu6-SP6-11 in the rat Psychopharmacology (Berl.) 100 1990 308 315 (Pubitemid 20052416)
36. L. Rozzini, B.V. Chilovi, E. Bertoletti, M. Conti, I. Del Rio, M. Trabucchi, and A. Padovani Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment Int. J. Geriatr. Psychiatry 21 2006 550 555 (Pubitemid 44043756)
37. C. Sarti, L. Pantoni, L. Bartolini, and D. Inzitari Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models J. Neurol. Sci. 203-204 2002 263 266 (Pubitemid 35287408)
38. K.M. Sink, X. Leng, J. Williamson, S.B. Kritchevsky, K. Yaffe, L. Kuller, S. Yasar, H. Atkinson, M. Robbins, B. Psaty, and D.C. Goff Jr. Centrally active ACE inhibitors may slow cognitive decline: the cardiovascular health study Arch. Intern. Med. 169 13 2009 1195 1202
39. R.A. Skidgel, S. Engelbrecht, A. Johnson, and E.G. Erdos Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase Peptides 5 1984 769 776 (Pubitemid 14058557)
40. Y. Tang, and T.G. Aigner Release of cerebral acetylcholine increases during visually mediated behavior in monkeys Neuroreport 7 13 1996 2231 2235 (Pubitemid 26361852)
41. Y. Tang, M. Mishkin, and T.G. Aigner Effects of muscarinic blockade in perirhinal cortex during visual recognition Proc. Natl. Acad. Sci. U. S. A. 94 23 1997 12667 12669 (Pubitemid 27492586)
42. C. Tomaz, and P.J. Nogueira Facilitation of memory by peripheral administration of substance P Behav. Brain Res. 83 1997 143 145 (Pubitemid 27086627)
43. C. Tzourio, C. Dufouil, P. Ducimetière, and A. Alpérovitch Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging Neurology 53 9 1999 1948 1952
44. C. Tzourio, C. Anderson, N. Chapman, M. Woodward, B. Neal, S. MacMahon, J. Chalmers PROGRESS Collaborative Group Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch. Intern. Med. 163 2003 1069 1075 (Pubitemid 36548935)
45. P. Usinger, F.J. Hock, G. Wiemer, H.J. Gerhards, R. Henning, and H. Urbach Hoe 288: indications on the memory-enhancing effects of a peptidase inhibitor Drug Dev. Res. 14 3-4 1988 315 324 (Pubitemid 19156350)
46. A. Viswanathan, W.A. Rocca, and C. Tzourio Vascular risk factors and dementia: how to move forward? Neurology 72 4 2009 368 374
47. J. Wang, H.Y. Zhang, and X.C. Tang Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion J. Neurosci. Res. 88 2010 807 815
48. E.C. Warburton, T. Koder, K. Cho, P.V. Massey, G. Duguid, G.R. Barker, J.P. Aggleton, Z.I. Bashir, and M.W. Brown Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory Neuron 38 6 2003 987 996 (Pubitemid 36782388)
49. B.D. Winters, and T.J. Bussey Removal of cholinergic input to perirhinal cortex disrupts object recognition but not spatial working memory in the rat Eur. J. Neurosci. 21 8 2005 2263 2270 (Pubitemid 40695251)
50. J.M. Wyss, I. Kadish, and T. van Groen Age-related decline in spatial learning and memory: attenuation by captopril Clin. Exp. Hypertens. 25 2003 455 474 (Pubitemid 37204430)
51. K. Yamada, S. Uchida, S. Takahashi, M. Takayama, Y. Nagata, N. Suzuki, S. Shirakura, and T. Kanda Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease Brain Res. 1352 2010 176 186
52. S. Yasar, J. Zhou, R. Varadhan, and M.C. Carlson The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women Clin. Pharmacol. Ther. 84 2008 119 126 (Pubitemid 351861493)
53. K. Zou, T. Maeda, A. Watanabe, J. Liu, S. Liu, R. Oba, Y. Satoh, H. Komano, and M. Michikawa Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme J. Biol. Chem. 284 2009 31914 31920